MoneyWorks4Me

Pfizer - Quaterly Results

19 May 2025 Evaluate
The revenue zoomed 8.28% to Rs. 5919.10 millions for the quarter ended March 2025 as compared to Rs. 5466.30 millions during the corresponding quarter last year.Profit after tax for the quarter ended March 2025 reported a huge growth of 85.03% to Rs. 3309.40  millions from Rs. 1788.60 millions.The company reported a good operating profit of 2720.80 millions compared to 2645.60 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 5919.10 5466.30 8.28 22813.50 21931.70 4.02 22813.50 21931.70 4.02
Other Income 445.80 751.30 -40.66 1722.50 1805.10 -4.58 1722.50 1805.10 -4.58
PBIDT 2720.80 2645.60 2.84 9124.80 8158.10 11.85 9124.80 8158.10 11.85
Interest 26.90 69.50 -61.29 84.10 154.10 -45.43 84.10 154.10 -45.43
PBDT 4422.00 2576.10 71.65 10768.80 8083.50 33.22 10768.80 8083.50 33.22
Depreciation 164.00 137.50 19.27 607.90 622.80 -2.39 607.90 622.80 -2.39
PBT 4258.00 2438.60 74.61 10160.90 7460.70 36.19 10160.90 7460.70 36.19
TAX 948.60 650.00 45.94 2484.90 1947.40 27.60 2484.90 1947.40 27.60
Deferred Tax -42.00 163.10 -125.75 -156.10 361.10 -143.23 -156.10 361.10 -143.23
PAT 3309.40 1788.60 85.03 7676.00 5513.30 39.23 7676.00 5513.30 39.23
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 45.97 48.40 -5.02 40.00 37.20 7.53 40.00 37.20 7.53
Peers
Company Name CMP
Sun Pharma. Inds. 1851.55
Dr. Reddys Labs. 1212.95
Cipla 1385.40
Lupin 2118.25
Zydus Lifesciences 1172.55
View more..